The bioT3 Platform

Ralph V. Boccia, MD, FACP

Video Categories: PMO Interview with the Innovator Series: Volume 9

Dr. Boccia describes the components of the bioT3 platform and its clinical utility in identifying tumor type and actionable targets for therapy.
January 20, 2016

Resistant and Mutational Cells

Dr Wainberg and Dr Gerson talk about the efficacy limitations of cytotoxic chemotherapy on some cells for a variety of reasons.

July 29, 2015

Improving the Standard of Care

Dr. Jorge Cortes discusses how to improve the current standard of care by better utilizing the drugs and treatments that are already available.